The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma
Crossref DOI link: https://doi.org/10.1007/s00268-016-3649-0
Published Online: 2016-09-08
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hiyoshi, Yukiharu
Yoshida, Naoya
Watanabe, Masayuki
Kurashige, Junji
Baba, Yoshifumi
Sakamoto, Yasuo
Baba, Hideo
Version of Record valid from 2016-09-08
License valid from 2016-09-08